Tumor's amino acids train white blood cells to fight back
Clinical trial at UCLA
The DCVax clinical trial at UCLA's Jonsson Comprehensive Cancer Center remains open to patients who have glioblastoma brain cancer. For information, call 310-267-2621 or visit http://www.cancer.ucla.edu.
The brain tumor that threatened to kill Lupe Carrillo is now being used to help him survive.
The 61-year-old Oxnard man, diagnosed with a cancer that carries a 98 percent fatality rate, is being treated with an experimental vaccine made of his own white blood cells and amino acids from the tumor.
Like a search-and-rescue dog trained to follow a scent, the amino acids are used in a UCLA clinical trial to teach Carrillo's immune system to recognize and fight cells from his specific cancer.
0 comments:
Post a Comment